How Could a New Longevity Medicine Create $200B Per Year in Revenue? Dr. Greg Bailey and I asked top VC Alex Colville from age1
Longevity for Investors with Dr. Greg Bailey and Jess Larsen
00:00
The emergence and implications of synthetic embryos
Alex describes synthetic embryos/integrated stem cell models, recent papers and startups, and ethical and therapeutic opportunities for cell therapies and fertility.
Transcript
Play full episode
